SARM1 senses dsDNA to promote NAD+ degradation and cell death
Cell · 2025-12 · 188 (25) · 7137-7154.e21
DOI: 10.1016/j.cell.2025.09.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-12. Verfasst von Lina Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning 116044, China; Department of Cancer Research, Harbin Medical University Ca…. Hauptthemen laut MEDLINE: Armadillo Domain Proteins, Cytoskeletal Proteins, NAD, DNA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China National Outstanding Youth Science Fund Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Detection of DNA is a fundamental strategy for life to recognize non-self or abnormal-self to subsequently trigger the downstream responses. However, the mechanism underlying DNA sensing is incompletely understood. Here, we show that a key neural executioner, sterile alpha and Toll/interleukin-1 receptor (TIR) motif containing 1 (SARM1), senses double-stranded DNA (dsDNA) to promote cell death. dsDNA-bound and -activated SARM1 to degrade nicotinamide adenine dinucleotide (NAD+) in a sequence-independent manner. SARM1 bound dsDNA via the TIR domain, and lysine residues in the TIR domain contributed to dsDNA binding. In the cellular context, cytosolic dsDNA from dsDNA transfection or chemotherapy treatment was colocalized with SARM1 and activated SARM1 to elicit NAD+ degradation and cell death, which was abrogated by SARM1 knockout or DNA-binding residue mutation. Consistently, SARM1 knockout blocked chemotherapy-induced neuropathy (CIN) in mice. Our results reveal SARM1 as a DNA sensor, which might be targetable for therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning 116044, China; Department of Cancer Research, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150000, China.
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning 116044, China.
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China.
- CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning 116023, China.
- Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, China.
- Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116044, China.
Förderung
- National Natural Science Foundation of China National Outstanding Youth Science Fund Project
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Liu, Q., Li, S., Wang, N., Chen, Y., Chen, J., Wang, L., Huang, Y., Sun, Z., Dong, L., Li, S., Liu, Q., Gao, S., Ma, X., Song, C., & Yang, Q. (2025). SARM1 senses dsDNA to promote NAD+ degradation and cell death. Cell, 188(25), 7137-7154.e21. https://doi.org/10.1016/j.cell.2025.09.026
Vancouver
Wang L, Liu Q, Li S, Wang N, Chen Y, Chen J, et al. SARM1 senses dsDNA to promote NAD+ degradation and cell death. Cell. 2025;188(25):7137-7154.e21. doi:10.1016/j.cell.2025.09.026
BibTeX
@article{Wang2025,
author = {Wang, Lina and Liu, Qiaoling and Li, Siru and Wang, Na and Chen, Yan and Chen, Junren and Wang, Li and Huang, Yuelin and Sun, Zhen and Dong, Ling and Li, Shao and Liu, Quentin and Gao, Song and Ma, Xiaochi and Song, Chengli and Yang, Qingkai},
title = {SARM1 senses dsDNA to promote NAD+ degradation and cell death},
journal = {Cell},
year = {2025},
volume = {188},
number = {25},
pages = {7137--7154.e21},
doi = {10.1016/j.cell.2025.09.026}
}
EUVIMED